Results 171 to 180 of about 186,524 (347)

Patient‐specific modifiers of survival benefit in cardiac resynchronization therapy ‐ A multicentre interaction analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Background Cardiac resynchronization therapy (CRT) is a key intervention for patients with heart failure. The choice between a CRT with defibrillator therapy (CRT‐D) and a CRT with pacemaker (CRT‐P) is influenced by individual clinical characteristics.
Bert Vandenberk   +14 more
wiley   +1 more source

Externally Rechargeable Cardiac Pacemaker

open access: bronze, 1965
Arthur W. Silver   +3 more
openalex   +1 more source

Diagnostic value of computed tomography‐based muscle quality and metabolic signatures in heart failure with sarcopenia

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Sarcopenia is a major comorbidity in heart failure (HF) patients, but its comprehensive evaluation remains challenging due to resource limitations. Computed tomography (CT) imaging allows opportunistic assessment of both muscle quantity and quality; however, its diagnostic utility and relationships with physical performance and underlying
Wataru Kawaharata   +13 more
wiley   +1 more source

Physiological studies and clinical experience in patients with synchronous and asynchronous pacemakers

open access: bronze, 1966
Stanley K. Brockman   +4 more
openalex   +1 more source

Rationale and design of the randomized ‘early ventricular assist device’—Trial (VAD‐DZHK3)

open access: yesESC Heart Failure, EarlyView.
The VAD‐DZHK3 trial is a randomised controlled study evaluating whether elective LVAD implantation improves outcomes in end‐stage heart failure (HF) patients listed for heart transplantation compared with delayed implantation after clinical deterioration.
Christoph Knosalla   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy